Pharmafile Logo
Pharmafocus logo
Advanced Search

addiction

Showing 7 posts of 7 posts found.

NICE to set out new opioid prescription guidelines for GPs

March 18, 2019
Sales and Marketing GPs, NICE, addiction, addictive drugs, opioids, prescription drugs, withdrawal

NICE is set to develop new guidelines for GPs and healthcare professionals setting out rules for doctors regarding opioids and …

News
opioid_pills

Prescription painkillers reclassified amid addiction concerns

October 17, 2018
Research and Development UK, addiction, classification, painkillers, policy

Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of …

News
nice_new_london_office_internal_2_8

NICE guidelines on antidepressant withdrawal symptoms are misleading, study shows

October 9, 2018
Manufacturing and Production NICE, UK, addiction, antidepressants, research, study

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …

News
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …

News
crack_cocaine

Weight loss drugs could be used to treat cocaine addiction

September 21, 2017
Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …

News

FDA approves first buprenorphine implant for opioid dependence

May 27, 2016
Medical Communications, Sales and Marketing FDA, addiction, buprenorphine, dependence, implant, opioid, probuphine

The US Food and Drug Administration (FDA) has approved Probuphine, which is the first buprenorphine implant for the maintenance treatment …

News
fda_sign_web

FDA announces strongest warnings for opioid pain medications

March 23, 2016
Medical Communications, Research and Development FDA, abuse, addiction, boxed, label, misuse, opioids, public health, restrictions, safety, warnings

The US Food and Drug Administration has announced class-wide safety labelling changes for immediate release (IR) opioid pain medications. The …

News

Latest content

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023

Acesion Pharma raises €45m series B funding

September 26, 2023

CDC Advisory Committee recommends Pfizer’s RSV vaccine

September 25, 2023

FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment

September 25, 2023

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023